Concepedia

R. Valente

RV

Statistics

Publications

14

Citations

1.7K

H-Index

14

Active since

1988

Affiliations

Bristol-Myers Squibb (Germany)(Current)

Bristol-Myers Squibb (United States)

Instituto Nacional de Rehabilitación Psicofísica

The University of Texas Southwestern Medical Center

University of Colorado Denver

R. Valente is an author at Bristol-Myers Squibb (Germany) specializing in medicine, rheumatology, and rheumatoid arthritis.

Publications per year

1988–2022

14

Publications

14

A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

John H. Stone, Gary S. Hoffman, Peter A. Merkel et al. · Arthritis & Rheumatism · 2001 · 466 citations

, , +13

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Michael Schiff, Michael E. Weinblatt, R. Valente et al. · Annals of the Rheumatic Diseases · 2013 · 292 citations · Full text

, , +16

Head‐to‐head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

Michael E. Weinblatt, Michael Schiff, R. Valente et al. · Arthritis & Rheumatism · 2012 · 248 citations · Full text

, , +14

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

M. C. Genovese, A. Covarrubias, G. Léon et al. · Arthritis & Rheumatism · 2011 · 195 citations · Full text

, , +14

Prognostic markers of radiographic progression in early rheumatoid arthritis

Jörg J. Goronzy, Eric L. Matteson, James W. Fulbright et al. · Arthritis & Rheumatism · 2004 · 168 citations

, , +17

1–5 of 14